# If Biogen Inc. moves, who benefits? How far does the value-chain ripple reach?
Canonical: https://valuechain.wiki/biogen · Facet: ripple · Updated: 2026-09-23T09:44:39.939106+00:00 · Source: ValueChain.wiki (cited money-flow graph)

**Citable summary**: Per the valuechain.wiki graph, Biogen Inc. is directly linked to 4 companies (2 supply, 3 revenue relationships) and reaches 6 companies within two hops; the links are backed by 6 dated sources, 2 of them primary filings (as of 2026-09-23).

Biogen Inc. operates across Neuroscience therapeutics company. It is +25.5% in 2026. Demand side (avg +4.8%), the stock (+25.5%) and supply side (avg +8.6%) are moving in step. Propagation has completed a lap, so the next leg depends on individual results more than chain direction. Among connected nodes the furthest ahead is McKesson Corporation (+11%) and the furthest behind is Cencora, Inc. (-1.4%). If chain logic explains the gap, the laggard is the next propagation candidate; if not, the link itself deserves a second look. It spends on licensed drug candidates, joint development and outsourced biologics manufacturing.

## Demand chain (leading)
- T1 Cencora, Inc. (https://valuechain.wiki/cencora.md)
- T1 McKesson Corporation (https://valuechain.wiki/mckesson.md)
- T2 CVS Health (https://valuechain.wiki/cvs-health.md)
- T3 Elevance Health, Inc. (https://valuechain.wiki/elevance-health.md)
- T2 Walmart Inc (https://valuechain.wiki/walmart.md)
- T3 UnitedHealth Group Incorporated (https://valuechain.wiki/unitedhealth-group.md)
- T1 Eisai (https://valuechain.wiki/eisai.md)

## Supply chain (benefiting)
- T1 Fujifilm Holdings (https://valuechain.wiki/fujifilm-holdings.md)
- T1 Eisai (https://valuechain.wiki/eisai.md)

---
Full node: https://valuechain.wiki/biogen.md · JSON: https://valuechain.wiki/biogen.json